Dr. Haller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-265-0111Fax+1 352-265-5420
Education & Training
- University of FloridaFellowship, Pediatric Endocrinology, 2003 - 2006
- University of FloridaResidency, Pediatrics, 2000 - 2003
- University of Florida College of MedicineClass of 2000
Certifications & Licensure
- FL State Medical License 2004 - 2025
- NC State Medical License 2017 - 2025
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT) Start of enrollment: 2005 Apr 01
- Umbilical Cord Blood Infusion to Treat Type 1 Diabetes Start of enrollment: 2005 Apr 01
- Neulasta in Type 1 Diabetes Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 50 citationsISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents.Rachel E J Besser, Kirstine J Bell, Jenny J Couper, Anette-G Ziegler, Diane K Wherrett
Pediatric Diabetes. 2022-12-01 - 422 citationsIdentification of tissue-specific cell death using methylation patterns of circulating DNA.Roni Lehmann-Werman, Daniel Neiman, Hai Zemmour, Joshua Moss, Judith Magenheim
Proceedings of the National Academy of Sciences of the United States of America. 2016-03-29 - 51 citationsApplication of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling.Daniel J. Perry, Clive Wasserfall, Richard A. Oram, MacKenzie D. Williams, Amanda L. Posgai
Scientific Reports. 2018-03-14
Journal Articles
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 DiabetesTeresa Quattrin, Michael J Haller, Andrea K Steck, Eric I Felner, The New England Journal of Medicine
Press Mentions
- How a Pioneering Diabetes Drug Offers Hope for Preventing Autoimmune DisordersFebruary 15th, 2023
- Florida’s Transgender Debate Affecting Treatment, SurgeriesAugust 29th, 2022
- Diabetes Patients' DIY Solutions Are Still the Standard of CareOctober 22nd, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: